Skip to main content
SpringerLink
Log in

Kombinierte Pharmako- und Psychotherapie

  • Chapter
Grundlagen der Neuro-Psychopharmakologie

Zusammenfassung

Für eine Kombination von Psychopharmaka und Psychotherapie/psychosozialen Maßnahmen in der Behandlung psychiatrischer Erkrankungen sprechen mehrere Gründe:

  • Therapieresistenz: additive Behandlung, da Psychopharmaka of nicht ausreichend wirken

  • Mangelnde Compliance: Durch Psychotherapie kann die Motivation zur Behandlung gefördert werden, verbessert Krankheitsbewältigung, Krankheitseinstellung

  • Wegen Nebenwirkungen kann of keine therapeutisch suffiziente Medikamentendosis verabreicht werden

  • Psychotherapeutische Bearbeitung der psychosozialen Konsequenzen der psychiatrischen Erkrankung wie Defizite in Alltagsfertigkeiten, Behinderungen im familiären und beruflichen Bereich sowie Freizeitbereich

  • Stabilisierung des mit Psychopharmaka erreichten Therapieerfolges nach Absetzen der Medikation

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Psychiatric Association (2004) Practice Guideline for the Treatment of Patients with Schizophrenia, Second Edition, American Journal of Psychiatry 161 (Suppl)

    Google Scholar 

  • Bandelow B, Zohar J, Hollander E et al. (2007) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and postraumatic stress disorders. World J Biol Psychiatry 8: 175–187

    Article  PubMed  Google Scholar 

  • Bark N, Revheim N, Huq F et al. (2003) The impact of cognitive remediation on psychiatric symptoms in schizophrenia. Schizophr Res 63: 229–235

    Article  PubMed  Google Scholar 

  • Barlow DH, Gorman JM, Shear MK et al. (2000) Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 283: 2529–2536

    Article  CAS  PubMed  Google Scholar 

  • Blomhoff S, Haug TT, Hellström K et al. (2001) Randomized controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. Br J Psychiatry 179: 23–30

    Article  CAS  PubMed  Google Scholar 

  • Buchkremer G, Klingberg S, Holle R (1997) Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up. Acta Psychiatr Scand 96: 483–491

    Article  CAS  PubMed  Google Scholar 

  • Browne G, Steiner M, Roberts J et al. (2002) Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of ef ectiveness and costs. J Affect Dis 68: 317–330

    Article  PubMed  Google Scholar 

  • Colom F, Vieta E (2004) A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients. Bipolar Disord 6: 480–486

    Article  PubMed  Google Scholar 

  • Cormak I, Jones C, Campell C (2004) Cognitive behaviour therapy for schizophrenia. (Cochrane Review). In: The Cochrane Library, Issue 2. John Wiley & Sons Ltd. Chichester, UK

    Google Scholar 

  • Davidson JR, Foa EB, Huppert JD et al. (2004) Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 61: 1005–1013

    Article  CAS  PubMed  Google Scholar 

  • De Maat SM, Dekker J, Schoevers RA et al. (2007) Relative ef cacy of psychotherapy and combinated therapy in the treatment of depression: A metaanalysis. Eur Psychiatry 22: 1–8

    Article  PubMed  Google Scholar 

  • Deutsche Gesellschaft Für Psychiatrie, Psychotherapie Und Nervenheilkunde (Hrsg.) (2006) S3 Praxisleitlinien in Psychiatrie und Psychotherapie. Steinkopff Verlag Darmstadt

    Google Scholar 

  • Drury V, Birchwood M, Chochrane R (2000) Cognitive therapy and recovery from acute psychosis: a controlled trial. Br J Psychiatry 177: 8–14

    Article  CAS  PubMed  Google Scholar 

  • Falloon IRH, Liberman RP (1983) Interactions between drug and psychosocial therapy in schizophrenia. Schizophr Bull 9: 543–554

    Article  CAS  PubMed  Google Scholar 

  • Foa EB, Liebowitz MR, Kozak MJ et al. (2005) Randomized, placebo-controlled trial of exposure and ritual prevention. Clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 162: 151–161

    Article  PubMed  Google Scholar 

  • Frank E, Kupfer DJ, Thase ME et al. (2005) Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorders. Arch Gen Psychiatry 62: 996–1004

    Article  PubMed  Google Scholar 

  • Frank E, Kupfer JD, Buysse DJ et al. (2007) Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. Am J Psychiatry 164: 761–767

    Article  PubMed  PubMed Central  Google Scholar 

  • Furukawa TA, Wantanabe N, Churchill R (2006) Psychotherapy plus antidepressant for panic disorder with or without agoraphobia. Br J Psychiatry 188: 305–312

    Article  PubMed  Google Scholar 

  • Gabbard GO, Lazar SG, Homberg J (1997) The economic impact of psychotherapy: a review. Am J Psychiatry 154: 147–155

    Article  CAS  PubMed  Google Scholar 

  • Gaebel W, Weinmann S, Sartorius N (2005) Schizophrenia practice guidelines: international survey and comparison. Br J Psychiatry 187: 248–255

    Article  PubMed  Google Scholar 

  • Hautzinger M, Meyer TD (2007) Psychotherapie bei bipolaren affektiven Störungen. Nervenarzt 78: 1248–1260

    Article  CAS  PubMed  Google Scholar 

  • Herpertz SC, Mundt CH (2008) in Herpertz SC, Caspar F, Mundt Ch (Hrsg.) Kombination von Psychotherapie und Psychopharmakotherapie. Urban und Fischer, München, Jena

    Chapter  Google Scholar 

  • Hirschfeld RMA, Dunner DL, Keitner G et al. (2002) Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy and their combination. Biol Psychiatry 51: 123–133

    Article  PubMed  Google Scholar 

  • Hogarty GE, Kornblith SJ, Greenwald D et al. (1997) Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. Am J Psychiatry 154: 1504–1513

    Article  CAS  PubMed  Google Scholar 

  • Hogarty GE, Flesher S, Ulrich R et al. (2004) Cognitive enhancement therapy for schizophrenia: Effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 61: 866–876

    Article  PubMed  Google Scholar 

  • Hohagen F, Winkelmann G, Rasche RH et al. (1998) Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multi-centre study. Br J Psychiatry Suppl 35: 71–78.

    Google Scholar 

  • Kampman M, Keijsers GPJ, Hoogduin CAL et al. (2002) A randomized, double blind, placebo-controlled study of the effects of adjuntice paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. J Clin Psychiatry 63: 772–777

    Article  CAS  PubMed  Google Scholar 

  • Karp JF, Buysse DJ, Houck PR et al. (2004) Relationship of variability in residual symptoms with recurrence of major depressive disorder during maintenance treatment. Am J Psychiatry 161: 1877–1884

    Article  PubMed  Google Scholar 

  • Katschnig H, Konieczna T, Etzersdorfer E (1992) Psychosoziale Maßnahmen und Neuroleptika Langzeitmedikation. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd 4: Neuroleptika. Springer-Verlag, Wien, S169–183

    Google Scholar 

  • Katschnig H, Windhaber H (1998) Die Kombination einer Neuroleptika-Langzeitmedikation mit psychosozialen Maßnahmen. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka Bd 4: Neuroleptika, 2. Auf. Springer-Verlag, Wien, S169–183

    Google Scholar 

  • Keller MB, Mccullough JP, Klein DN et al. (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342: 1462–1470

    Article  CAS  PubMed  Google Scholar 

  • Klingberg S, Borbe R, Buchkremer B et al. (2006) Evidenzbasierte Psychotherapie schizophrener Störungen. Nervenarzt (Suppl 2) 77: 99–110

    Article  Google Scholar 

  • Lam D, Hayward P, Watkins ET et al. (2005) Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years. Am J Psychiatry 162: 324–329

    Article  PubMed  Google Scholar 

  • Lenze EJ, Dew MA, Mazumdar S et al. (2002) Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects on social adjustment. Am J Psychiatry 159: 466–468

    Article  PubMed  Google Scholar 

  • Lewis S, Tarrier N, Haddok G et al.(2002) Randomised controlled trial of cognitive-behavioral therapy in early schizophrenia: Acute-phase outcomes. Br J Psychiatry (Suppl) 43: 91–S97

    Article  Google Scholar 

  • Marcus SM, Gorman J, Shear MK et al. (2007) A comparison of medication side effects reports by panic disorder patients with and without concomitant cognitive behavior therapy. Am J Psychiatry 164: 273–275

    Article  PubMed  Google Scholar 

  • Mcgorry PD, Yung AR, Phillips LJ et al. (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59: 921–928

    Article  PubMed  Google Scholar 

  • Mcgurk SR, Twamley EW, Sitzer DI et al. (2007) A metaanalysis of cognitive remediation in schizophrenia. Am J Psychiatry 164 (12): 1791–1802

    Article  PubMed  PubMed Central  Google Scholar 

  • Miklowitz DJ, Otto MW, Frank E et al. (2007) Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry 64: 419–426

    Article  PubMed  PubMed Central  Google Scholar 

  • Morrison AP, French P, Walford L (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 185, 291–297

    Article  PubMed  Google Scholar 

  • Mueller DR, Roder V (2007) Integrated psychological therapy for schizophrenia patients. Expert Rev Neurother 7: 1–3

    Article  PubMed  Google Scholar 

  • National Institute For Clinical Excellence (2003) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. National Clinical Practice Guideline: www.nice.org.uk

    Google Scholar 

  • Nemeroff CB, Heim CM, Thase ME et al. (2003) Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA 100: 14293–14296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O`Connor KP, Aardema F, Robillard S et al. (2006) Cognitive behaviour therapy and medication in the treatment of obsessive-compulsvie disorder. Acta Psychiatr Scand 113: 408–419

    Article  PubMed  Google Scholar 

  • Österreichische Gesellschaft FÜr Psychiatrie Und Psychotherapie (2002) 4 × 8 Empfehlungen zur Behandlung von Schizophrenie. Edition pro mente, Linz

    Google Scholar 

  • Pampallona S, Bollini P, Tibaldi F et al. (2004) Combined pharmacotherapy and psychological treatment for depression. A systematic review. Arch Gen Psychiatry 61: 714–719

    Article  PubMed  Google Scholar 

  • Pharoah FM, Rathbone J, Mari JJ (2003) Family intervention for schizophrenia. Cochrane Database Syst Rev

    Google Scholar 

  • Perlis RH, Nierenberg AA, Alpert JE et al. (2002) Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacology 22: 474–480

    Article  CAS  Google Scholar 

  • Pitschel-Walz G, Leucht S, BÄuml J et al. (2001) The effect of family interventions on relapse and rehospitalization in schizophrenia — A Meta-Analysis. Schizophr Bull 27: 73–92

    Article  CAS  PubMed  Google Scholar 

  • Rathod S, Kingdon D, Weide P et al. (2008) Cognitivebehavioral therapy of a medication-resistant schizophrenia: A review. J Psychiatr Pract 4: 22–33

    Article  Google Scholar 

  • Reynolds CF, Frank E, Perel JM et al. (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281: 39–45.

    Article  CAS  PubMed  Google Scholar 

  • Schramm E, Van Calker D, Dykierek P et al. (2007) An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. Am J Psychiatry 164: 768–777

    Article  PubMed  Google Scholar 

  • Scott J, Colom F, Vieta E (2007) A meta-analysis of relapse with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacology 10: 123–129

    Article  CAS  Google Scholar 

  • Sensky T, Turkington D, Kingdon D et al. (2000) A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 57: 163–172

    Article  Google Scholar 

  • Simpson HB, Huppert JD, Petkova E et al. (2006) Response versus remission in obsessive-compulsive disorder J Clin Psychiatry 67: 269–276

    Article  CAS  PubMed  Google Scholar 

  • Stein MB, Ron Norton G, Walker JR et al. (2000) Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorders. A pilot study. Psychiatry Res 94: 191–200

    Article  CAS  PubMed  Google Scholar 

  • Tarrier N, Lewis S, Haddock G et al. (2004) Cognitive — behavioural therapy in first — episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. Br J Psychiatry 184: 231–239

    Article  PubMed  Google Scholar 

  • Teasdale JD, Segal ZV, Williams JMG et al. (2000) Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 68: 615–623

    Article  CAS  PubMed  Google Scholar 

  • Thase ME, Greenhouse JB, Frank E et al. (1997) Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 54: 1009–1015

    Article  CAS  PubMed  Google Scholar 

  • Thase ME, Freidman SE, Biggs MM (2007) Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A Star*D Report. Am J Psychiatry 164: 739–752

    Article  PubMed  Google Scholar 

  • Thompson LW, Coon DW, Gallagher-Thompson D et al. (2001) Comparison of desipramine and cognitive/ behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry 9: 225–240

    Article  CAS  PubMed  Google Scholar 

  • Turkington D, Sensky T, Scott J et al. (2008) A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: A five-year follow up. Schizophr Res 98: 1–7

    Article  PubMed  Google Scholar 

  • Van Balkom AJL, De Haan E, Van Oppen P et al. (1998) Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive-compulsive disorder. J Nerv Ment Disease 186:492–499

    Article  Google Scholar 

  • Voderholzer U, Hohagen F (2007, 2008) (Hrsg) Therapie psychischer Erkrankungen. State of the Art. Urban & Fischer, München, Jena

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien Abteilung für Sozialpsychiatrie, Währinger Gürtel 18-20, 1090, Wien, Österreich

    Univ.-Prof. DDr. Gabriele Sachs

  2. Ludwig Boltzmann Institut für Sozialpsychiatrie, Lazarettgasse 14A, 1090, Wien, Österreich

    Univ.-Prof. Dr. med. Heinz Katschnig

Authors
  1. Univ.-Prof. DDr. Gabriele Sachs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Univ.-Prof. Dr. med. Heinz Katschnig
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie, Klinische Neurochemie, Universität Würzburg, Deutschland

    Peter Franz Riederer

  2. Inn-Salzach-Klinikum gGmbH, Fachkrankenhaus für Psychiatrie, Psychotherapie, Psychosomatische Medizin und Neurologie, Wasserburg a. Inn · Rosenheim · Freilassing, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München, Deutschland

    Gerd Laux

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Sachs, G., Katschnig, H. (2010). Kombinierte Pharmako- und Psychotherapie. In: Riederer, P.F., Laux, G. (eds) Grundlagen der Neuro-Psychopharmakologie. Springer, Vienna. https://doi.org/10.1007/978-3-211-85473-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-85473-0_20

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-85472-3

  • Online ISBN: 978-3-211-85473-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation